ResearcherEmory UniversityActive in the last 2 years
Parit T. Mavani
Matched on ORCID iD 0000-0003-3968-1205; OpenAlex author ID A5092727816. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2025: 1 paper · 2026: 2 papers
Papers 3
- Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma. First author DOI 10.1245/s10434-026-19132-z↗
- ASO Visual Abstract: Optimal Timing of Adjuvant Therapy for Patients with Poorly Differentiated Pancreatic Adenocarcinoma. First author DOI 10.1245/s10434-026-19311-y↗
- Ethics of Informed Consent with Comprehension of Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Co-author PMID 41835444↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David A. Kooby · 3 shared papers, 2025–2026 · strength 0.97
- Paper Ethics of Informed Consent with Comprehension of Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. PMID 41835444↗
- Paper Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma. DOI 10.1245/s10434-026-19132-z↗
- Paper ASO Visual Abstract: Optimal Timing of Adjuvant Therapy for Patients with Poorly Differentiated Pancreatic Adenocarcino… DOI 10.1245/s10434-026-19311-y↗
- Mihir Maheshkumar Shah · 3 shared papers, 2025–2026 · strength 0.97
- Paper Ethics of Informed Consent with Comprehension of Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. PMID 41835444↗
- Paper Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma. DOI 10.1245/s10434-026-19132-z↗
- Paper ASO Visual Abstract: Optimal Timing of Adjuvant Therapy for Patients with Poorly Differentiated Pancreatic Adenocarcino… DOI 10.1245/s10434-026-19311-y↗
- Theresa Wicklin Gillespie · 2 shared papers, 2026 · strength 0.60
- Juan Manuel Sarmiento · 2 shared papers, 2026 · strength 0.60
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.